Women's Health

Statins in AF patients cut risk of TIA; opioid makers must strengthen label warnings; individualized Rx reduces BP; and 2 more research quotes of note.

Your daily dose of clinical news you may have missed.

Pregnant women with prenatal depression were found to be more likely to be diagnosed with new CVD within 2 years of delivery than those without depression.

The shapes, sizes, and content of a US alcoholic drink-equivalent vary widely. Get a quick educational summary of the variety and more data that may help in your daily clinical practice.

Survey respondents facing the greatest increase in barriers to desired care were aged 25 to 29 years, identified as Hispanic, and lived below 100% of the federal poverty level.

Migraine disproportionately affects women, a disparity typically ascribed to hormonal differences. A new study takes a new look at the issue.

The FDA, women's health groups and professional societies, and state governors are all pushing back against the April 7 ruling by Texas District Judge Matthew Kacsmaryk.

Your daily dose of clinical news you may have missed.

Researchers found sex-specific brain signals that appear to confirm that different drivers lead men and women to develop obesity.

Your daily dose of clinical news you may have missed.

Researchers found no association between maternal opioid prescription postpartum and several adverse infant outcomes, including rehospitalization and emergency department visits.

Disparities in US health and health care delivery along some dimensions are moving backward, not forward, says AAFP president Iroku-Malize in this interview.

Statin-eligible patients in minority groups significantly undertreated; metabolically healthy obesity on the rise; menstruation irregularities suggest later CVD risk; and 2 more studies of note.

Your daily dose of clinical news you may have missed.

Women whose menstrual cycle varied in frequency had a significant 24% greater risk of a composite cardiovascular event during a 26-year follow-up, a new study reports.

Your daily dose of clinical news you may have missed.

A new study found the probability of initiating psycholeptics and having a postpartum psychiatric emergency was lower in early and late discontinuer groups vs the continuer group.

Fezolinetant, a nonhormonal selective neurokinin-3 receptor antagonist, significantly reduced frequency and severity of menopause-related VMS in a pivotal phase 3 trial.

Beginning on Sept 24, 2024, all women must be notified of their breast density status in mammography reports and encouraged to pursue supplemental screening.

Your daily dose of clinical news you may have missed.

ACC 2023. The Mediterranean diet has a beneficial effect on the primary prevention of cardiovascular disease and death in women, according to new analysis.

After coronary artery bypass surgery, women are still at higher risk for MI, stroke, and other adverse events than men despite years of improvement in technique and care.

Your daily dose of clinical news you may have missed.

Nitrous oxides were found to be the most damaging to bone architecture in the first study to look at the pollution-BMD association in postmenopausal women.

ACC 2023. Increasing rates of adverse pregnancy outcome over the last decade are largely attributable to a woman’s health status before she gets pregnant, rather than age, according to new research.

Many older adults show symptoms of food addiction, a new survey found. Is it time to start screening? A primary care physician considers the feasibility and the value.

Your daily dose of clinical news you may have missed.

Behavioral problems with food were found more common among women in their 50s and 60s and among men and women who report being lonely, in poor health, and overweight.

The novel findings suggest that continuation of aspirin therapy until gestation week 36 in those at high risk of preeclampsia may not be necessary in all cases.

A new review found that menopausal hormone therapy for vasomotor symptoms is safe and appropriate for most women at low atherosclerotic cardiovascular disease risk.